A recent work41 in mild depression in primary care setting suggested that chemokines such as SDF-1, MCP-1 and fractalkine are associated to a higher punctuation on the BDI scale, a finding that replicates for those three chemokines in our cohort of COVID-19 patients. Here, CX3CL1 is linked to depressive symptom measurement.